Targeted mRNA-LNPs for Tunable Engineering of the Immune System
Time: 9:30 am
day: Conference Day Two
Details:
- Describing the advantages and challenges presented by in vivo reprogramming of the immune system using non-cell based and non-viral based approaches
- Revealing the type and size of payload that can be delivered using LNPs to gain insights into the utilization of this technology
- Discussing the scalability, cost, and manufacturing of non-viral vectors such as LNPs to improve and streamline processes
- Examining the safety and efficacy of LNPs compared to other modes of delivery
